Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1417981

GTEX

daf0e30c-a822-526e-9019-ebcff98bc0bd

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • MYOGENESIS+0.122
  • KRAS_SIGNALING_DN+0.082
  • MITOTIC_SPINDLE+0.072
  • DNA_REPAIR+0.066
  • PI3K_AKT_MTOR_SIGNALING+0.058
  • SPERMATOGENESIS+0.033
  • APICAL_JUNCTION+0.000
  • PEROXISOME-0.003
  • UNFOLDED_PROTEIN_RESPONSE-0.004
  • WNT_BETA_CATENIN_SIGNALING-0.056

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.576
  • INTERFERON_GAMMA_RESPONSE-0.463
  • TGF_BETA_SIGNALING-0.435
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.425
  • KRAS_SIGNALING_UP-0.416
  • ALLOGRAFT_REJECTION-0.411
  • INFLAMMATORY_RESPONSE-0.407
  • IL6_JAK_STAT3_SIGNALING-0.393
  • TNFA_SIGNALING_VIA_NFKB-0.379
  • COAGULATION-0.362

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1401062
brain-umap@2
GTEX0.973
2SRR1472193
brain-umap@2
GTEX0.970
3SRR1398839
brain-umap@2
GTEX0.968
4SRR1490568
brain-umap@2
GTEX0.968
5SRR1327811
brain-umap@2
GTEX0.967
6SRR820468
brain-umap@2
GTEX0.966
7SRR1314187
brain-umap@2
GTEX0.966
8SRR1361736
brain-umap@2
GTEX0.966
9SRR1464305
brain-umap@2
GTEX0.965
10SRR1348770
brain-umap@2
GTEX0.965

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 6 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
MYOGENESIS0.122Inavolisib— uncovered
KRAS_SIGNALING_DN0.082Remibrutinib— uncovered
MITOTIC_SPINDLE0.072Inavolisib— uncovered
DNA_REPAIR0.066Idelalisib— uncovered
PI3K_AKT_MTOR_SIGNALING0.058Inavolisib— uncovered
SPERMATOGENESIS0.033Inavolisib— uncovered